Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04126200
Title Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 5)
Acronym DREAMM5
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | POL | NOR | NLD | ISR | GRC | FRA | ESP | DEU | CAN | BRA | AUS

Facility Status City State Zip Country Details
GSK Investigational Site RECRUITING Atlanta Georgia 30322 United States Details
GSK Investigational Site RECRUITING Indianapolis Indiana 46202 United States Details
GSK Investigational Site RECRUITING Boston Massachusetts 02215 United States Details
GSK Investigational Site RECRUITING Grand Rapids Michigan 49546 United States Details
GSK Investigational Site RECRUITING San Antonio Texas 78229 United States Details
GSK Investigational Site RECRUITING Madison Wisconsin 53792 United States Details
GSK Investigational Site RECRUITING Fitzroy Victoria 3065 Australia Details
GSK Investigational Site COMPLETED Melbourne Victoria 3000 Australia Details
GSK Investigational Site RECRUITING Salvador Bahía 41253-190 Brazil Details
GSK Investigational Site RECRUITING Porto Alegre Rio Grande Do Sul 90110-270 Brazil Details
GSK Investigational Site RECRUITING São Paulo 01236-030 Brazil Details
GSK Investigational Site RECRUITING São Paulo 04537-080 Brazil Details
GSK Investigational Site RECRUITING São Paulo 05652-900 Brazil Details
GSK Investigational Site RECRUITING Edmonton Alberta T6G 1Z2 Canada Details
GSK Investigational Site RECRUITING Vancouver British Columbia V5Z1M9 Canada Details
GSK Investigational Site RECRUITING Halifax Nova Scotia B3H 1V7 Canada Details
GSK Investigational Site RECRUITING Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site RECRUITING Lille Cedex 59037 France Details
GSK Investigational Site RECRUITING Lyon cedex 08 69373 France Details
GSK Investigational Site RECRUITING Mont-de-Marsan 40000 France Details
GSK Investigational Site RECRUITING Villejuif Cedex 94805 France Details
GSK Investigational Site RECRUITING Frankfurt am Main Hessen 60590 Germany Details
GSK Investigational Site RECRUITING Leipzig Sachsen 04103 Germany Details
GSK Investigational Site RECRUITING Kiel Schleswig-Holstein 24105 Germany Details
GSK Investigational Site RECRUITING Hamburg 20246 Germany Details
GSK Investigational Site RECRUITING Athens 11528 Greece Details
GSK Investigational Site RECRUITING Haifa 31096 Israel Details
GSK Investigational Site RECRUITING Petach Tikva 49100 Israel Details
GSK Investigational Site RECRUITING Tel Aviv 6423906 Israel Details
GSK Investigational Site RECRUITING Aichi 467-8602 Japan Details
GSK Investigational Site RECRUITING Ehime 790-8524 Japan Details
GSK Investigational Site RECRUITING Tokyo 150-8935 Japan Details
GSK Investigational Site RECRUITING Incheon 21565 Korea, Republic of Details
GSK Investigational Site RECRUITING Seoul 03080 Korea, Republic of Details
GSK Investigational Site RECRUITING Seoul 06351 Korea, Republic of Details
GSK Investigational Site RECRUITING Seoul 06591 Korea, Republic of Details
GSK Investigational Site RECRUITING Ulsan 44033 Korea, Republic of Details
GSK Investigational Site RECRUITING Mexico City 01330 Mexico Details
GSK Investigational Site WITHDRAWN Amsterdam 1081 HV Netherlands Details
GSK Investigational Site RECRUITING Dordrecht 3318 AT Netherlands Details
GSK Investigational Site RECRUITING Enschede 7512 KZ Netherlands Details
GSK Investigational Site RECRUITING Leeuwarden 8934 AD Netherlands Details
GSK Investigational Site RECRUITING Utrecht 3584 CX Netherlands Details
GSK Investigational Site RECRUITING Oslo 0450 Norway Details
GSK Investigational Site RECRUITING Gdansk 80-214 Poland Details
GSK Investigational Site RECRUITING Katowice 40-519 Poland Details
GSK Investigational Site RECRUITING Lodz 93-513 Poland Details
GSK Investigational Site RECRUITING Lublin 20-081 Poland Details
GSK Investigational Site RECRUITING Poznan 60-569 Poland Details
GSK Investigational Site RECRUITING Moscow 125284 Russian Federation Details
GSK Investigational Site RECRUITING St'Petersburg 191024 Russian Federation Details
GSK Investigational Site RECRUITING Badalona 08916 Spain Details
GSK Investigational Site RECRUITING Madrid 28027 Spain Details
GSK Investigational Site RECRUITING Madrid 28040 Spain Details
GSK Investigational Site RECRUITING Madrid 28041 Spain Details
GSK Investigational Site RECRUITING Pamplona 31008 Spain Details
GSK Investigational Site RECRUITING Pozuelo (Madrid) 28223 Spain Details
GSK Investigational Site RECRUITING Falun SE-791 82 Sweden Details
GSK Investigational Site RECRUITING Stockholm SE-141 86 Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field